Cost analysis of GenoType® MTBDRplus and GenoType® MTBDRsl at the State Laboratory of São Paulo, Brazil
Rev. Soc. Bras. Med. Trop
;
56: e0238, 2023. tab, graf
Article
Dans Anglais
|
LILACS-Express
| LILACS
| ID: biblio-1449347
ABSTRACT
ABSTRACT Background:
We aimed to evaluate the costs of GenoType® MTBDRplus and MTBDRsl incurred during the diagnosis of first- and second-line drug-resistant tuberculosis (TB) in São Paulo, Brazil.Methods:
Mean and activity-based costs of GenoType® were calculated in a referral laboratory for TB in Brazil.Results:
The mean cost value and activity-based cost of GenoType® MTBDRplus were USD 19.78 and USD 35.80 and those of MTBDRsl were USD 54.25 and USD 41.85, respectively.Conclusions:
The cost of GenoType® MTBDRplus was reduced owing to the high number of examinations performed and work optimization.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Type d'étude:
Évaluation en économique de la santé
Pays comme sujet:
Amérique du Sud
/
Brésil
langue:
Anglais
Texte intégral:
Rev. Soc. Bras. Med. Trop
Thème du journal:
Médecine tropicale
Année:
2023
Type:
Article
/
descriptif de projet
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Centro Universitário UNA/BR
/
Instituto Adolfo Lutz/BR
/
Universidade Federal de Minas Gerais/BR
/
Universidade Federal do Rio de Janeiro/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS